Shekhar Goyal, Akhil Kapoor, Indra Bhadu | International Journal of Clinical Trials | 2014 Aug;1(2):76-77 Abstract As per Drug Controller General of India (DCGI), there are clear cut compensation guidelines for clinical trial participants in case of death and injury after… Continue reading
Mukesh Yadav, Pramendra Singh Thakur, Pooja Rastogi | Journal of Indian Academy of Forensic Medicine (JIAFM) | Vol 36 No 2 | Apr-Jun 2014 | Pg 50 Hon’ble Supreme Court has shown its concern for protection of human rights of… Continue reading
Soumil Patwardhan, Nithya Gogtay, Urmila Thatte, C S Pramesh | Indian Journal of Medical Ethics | Vol 11, No 1 | 2014 Abstract Literature on the quality and completeness of data and documentation in investigator-initiated research studies is scarce. We… Continue reading
Neelambari Bhosale, Shagoofa Nigar, Soma Das, Uma Divate, Pathak Divate | Indian Journal of Medical Ethics | Vol 11 No 1 | 2014 Abstract The recent negative media reports on the status of participants in clinical trials in India, together… Continue reading
Ravindra B. Ghooi | Perspectives in Clinical Research | V4(4) | 2013 | Source NCBI-PMC Abstract Three amendments to the drugs and cosmetics rules were published in quick succession in 2013. These addressed the issues of compensation of injury and death… Continue reading
Joel Lexchin | Journal of Pharmaceutical Policy and Pract | 2013 | PubMed Central (PMC) | NCBI | Published online: Dec 2, 2013 Clinical trials present an ethical dilemma for pharmaceutical companies. While companies may want to undertake and report these… Continue reading
